Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
EV to Sales History
Trending lower, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1978.99
Near historical average
Average (5y)
2002.37
Historical baseline
Range
High:6233.69
Low:9.46
CAGR
-20.5%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1978.99 | -36.4% |
| 2023 | 3110.98 | +32768.6% |
| 2022 | 9.46 | -93.9% |
| 2021 | 155.19 | -70.5% |
| 2020 | 525.90 | -91.6% |
| 2019 | 6233.69 | - |